Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy

Details for Australian Patent Application No. 2002243411 (hide)

International Classifications

Event Publications

6 February 2003 Application Open to Public Inspection

Published as AU-B-2002243411

8 July 2004 Amendment Made

The nature of the amendment is: Amend the name of the applicant/patentee from Endeavor Pharmaceuticals to Endeavor Pharmaceuticals, Inc

8 July 2004 Assignment before Grant

Endeavor Pharmaceuticals, Inc The application has been assigned to Barr Laboratories, Inc.

8 February 2007 Application Accepted

Published as AU-B-2002243411

7 June 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

2 August 2007 Section 223 Application Allowed

Barr Laboratories, Inc. The time in which to pay the acceptance fees has been extended to 08 Jun 2007. Address for service in Australia - PIZZEYS GPO Box 1374 Brisbane QLD 4001

9 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.